在儿科癌症病理学实践中实施分子瘤分析:病理学家的经验

相关实验视频

Updated: May 1, 2026

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

Catherine K Gestrich1, Portia Kreiger2, Lea Surrey2

  • 1Department of Pathology, UPMC Children's Hospital of Pittsburgh, Pittsburgh, USA.

Pediatric blood & cancer
|October 10, 2024
PubMed
概括

儿科病理学家越来越多地使用分子检测,包括下一代测序 (NGS),用于儿童的固体瘤. 然而,成本和测试选择等障碍阻碍了更广泛的采用.

关键词:
一个分子分子的分子.这种新生体是瘤.儿科 儿科 儿科调查调查调查调查调查调查调查调查

更多相关视频

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids06:53

Detection and Monitoring of Tumor Associated Circulating DNA in Patient Biofluids

Published on: June 8, 2019

8.6K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

7.2K

相关概念视频

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K